Related Experiment Video
Updated: Oct 21, 2025
07:08
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
1.0K
Hereditary pancreatic cancer.
Kodai Abe1, Minoru Kitago1, Yuko Kitagawa1
1Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
International Journal of Clinical Oncology
|September 3, 2021
Summary
Identifying high-risk germline variants in pancreatic cancer is crucial. Active surveillance and PARP inhibitor therapy offer improved detection, prognosis, and precision medicine for patients with these genetic predispositions.
Area of Science:
- Oncology
- Genetics
- Medical Diagnostics
Background:
- Pancreatic cancer is linked to hereditary cancer syndromes and familial predispositions.
- Multigene panel testing identifies key high-risk germline variants (e.g., BRCA1/2, TP53, CDKN2A) in pancreatic cancer patients.
- Genome-wide association studies also reveal common, low-risk germline variants associated with pancreatic cancer.
Purpose of the Study:
- To review the significance of germline pathogenic variants in pancreatic cancer.
- To emphasize the role of surveillance and precision medicine in managing pancreatic cancer.
- To highlight potential improvements in diagnosis, prevention, and therapeutic strategies.
Main Methods:
- Review of current literature on germline variants in pancreatic cancer.
- Analysis of multigene panel testing results and genome-wide association studies.
- Discussion of surveillance methods (MRI, EUS) and therapeutic approaches (PARP inhibitors).
Main Results:
- Identified BRCA1/2, PALB2, ATM, TP53, MLH1, STK11/LKB1, APC, CDKN2A, and SPINK1/PRSS1 as high-risk genes for pancreatic cancer.
- Highlighted the clinical utility of active pancreatic surveillance for high-risk individuals.
- Demonstrated the efficacy of poly-ADP-ribose polymerase (PARP) inhibitors in BRCA-positive pancreatic cancer.
Conclusions:
- Germline variant surveillance is vital for early detection and improved prognosis in pancreatic cancer.
- Active surveillance strategies are recommended for individuals with family history or pathogenic germline variants.
- PARP inhibitor therapy represents a key advancement in precision medicine for BRCA-mutated pancreatic cancer.
Related Concept Videos
01:24Chronic Pancreatitis I: Introduction
336
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
336
01:20The Retinoblastoma Gene
4.3K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.3K
02:21Cancers Originate from Somatic Mutations in a Single Cell
13.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.3K
02:59Cancer Prevention
6.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.6K
01:33Cancer-Critical Genes I: Proto-oncogenes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
02:38The Ras Gene
6.6K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.6K